Abstract
Langerhans cells (LC) intersperse the epidermis forming a thin meshwork of sentinel cells. LC are members of the heterogeneous family of dendritic cells which are recognized to perform an exquisite immunosurveillance function. Distributed throughout the body and localized in nonlymphoid and lymphoid tissues, cells of this category are uniquely equipped to trigger a primary immune response (for review see ref. 1). Notably, processes related to the sentinel function such as antigen uptake and its degradation, and those involving antigen presentation with subsequent T cell priming are separated spatially and by time. Dendritic cells in distinct developmental stages perform these totally different functions. Thus, sentinel dendritic cells such as LC which reside in peripheral nonlymphoid sites are developmentally immature. They carry phenotypic markers of juvenile dendritic cells, i.e., submaximal levels of major histocompatibility complex (MHC) class I, class II and other markers.1
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271–96.
Inaba K, Inaba M, Naito M et al. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guérin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993; 178: 479–88.
Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993; 178: 509–19.
Scheicher C, Mehlig M, Dienes HP et al. Uptake of bead-absorbed versus soluble antigen by bone marrow-derived dendritic cells triggers their activation and increases their antigen presentation capacity. In: Banchereau J, Schmitt D, eds. Dendritic Cells in Fundamental and Clinical Immunology. New York: Plenum Publishing Corporation, in press.
Silberberg-Sinakin I, Thorbecke GJ, Baer RL et al. Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 1976; 25: 137–51.
Larsen CP, Steinman RM, Witmer-Pack M et al. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483–93.
Kripke ML, Munn CG, Jeevan A et al. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833–8.
Stössel H, Koch F, Kämpgen E et al. Disappearance of certain acidic organdies (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med 1990; 172: 1471–82.
Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985; 161: 526–46.
Shimada S, Caughman SW, Sharrow SO et al. Enhanced antigen-presenting capacity of cultured Langerhans’ cells is associated with markedly increased expression of Ia antigen. J Immunol 1987; 139: 2551–5.
Romani N, Lenz A, Glassel H et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989; 93: 600–9.
Streilein JW, Grammer SF. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J Immunol 1989; 143: 3925–33.
Girolomoni G, Simon JC, Bergstresser PR et al. Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short term culture. J Immunol 1990; 145: 2820–6.
Paglia P, Girolomoni G, Robbiati F et al. Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. J Exp Med 1993; 178: 1893–1901.
Becker D, Reske-Kunz AB, Knop J et al. Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells. Eur J Immunol 1991; 21: 1213–20.
Puré E, Inaba K, Crowley MT et al. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med 1990; 172: 1459–69.
Kämpgen E, Koch N, Koch F et al. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci USA 1991; 88: 3014–8.
Neiß U, Reske K. Non-coordinate synthesis of MHC class II proteins and invariant chains by epidermal Langerhans cells derived from short-term in vitro culture. Intern Immunol 1994; 6: 61–71.
Sant AJ, Cullen SE, Giacoletto KS et al. Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan. J Exp Med 1985; 162: 1916–34.
Naujokas MF, Morin M, Anderson MS et al. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 1993; 74: 257–68.
Aruffo A, Stamenkovic I, Melnick M et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303–13.
Fukomoto T, McMaster WR, Williams AF. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of la and class I antigens in rat thymus. Eur J Immunol 1982; 12: 237–43.
Fisch A, Reske K. Cell surface display of rat invariant y chain: detection by monoclonal antibodies directed against a C-terminal y chain segment. Eur J Immunol 1992; 22: 1413–9.
Henkes W, Syha J, Reske K. Nucleotide sequence of rat invariant gamma chain cDNA clone pLRgamma34.3. Nucleic Acids Res 1988; 16: 1 1822.
Bakke O, Dobberstein B. MHC class II associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990; 63: 707–16.
Lotteau V, Teyton L, Peleraux A et al. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990; 348: 600–5.
Harding CV, Roof RW, Unanue ER. Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange. Proc Natl Acad Sci USA 1989; 86: 4230–4.
Scheicher C, Mehlig M, Zecher R et al. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J Immunol Meth 1992; 154: 253–64.
Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693–1702.
Mehlig M, Scheicher C, Dienes HP et al. Development of rat DC by in vitro culture of bone marrow cells. In: Banchereau J, Schmitt D, eds. Dendritic Cells in Fundamental and Clinical Immunology. New York: Plenum Publishing Corporation, in press.
Ozato K, Mayer N, Sachs D. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 1980; 124: 533–40.
Dornmair K, Rothenhäusler B, McConnel HM. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harbor Symp Quant Biol 1989; 54: 409–16.
Germain RN, Hendrix LR. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 1991; 353: 134–9.
Nelson CA, Petzold SJ, Unanue ER. Peptides determine the life span of MHC class II molecules in the antigen-presenting cell. Nature 1994; 371: 250–2.
Fling SP, Arp B, Pious D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 1994; 368: 554–8.
Morris P, Shaman J, Attaya M et al. An essential role for HLADM in antigen presentation by class II major histocompatibility molecules. Nature 1994; 368: 551–4.
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Neiß, U., Demleitner, K., Marx, A., Mehlig, M., Scheicher, C., Reske, K. (1995). Antigen Presentation by Langerhans/Dendritic Cells. In: The Immune Functions of Epidermal Langerhans Cells. Medical Intelligence Unit. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22497-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-22497-7_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-22499-1
Online ISBN: 978-3-662-22497-7
eBook Packages: Springer Book Archive